Abstract
Early diagnosis and treatment of tuberculous meningitis (TBM) are essential to have a favourable treatment outcome. Demonstration of acid-fast bacilli in cerebrospinal fluid (CSF) smear is still one of the most dependable methods of diagnosis. Culture of CSF, though considered as most definitive diagnostic method, has limitation and is recommended when detection of drug resistance or characterization of mycobacterial species is required. Nonconventional culture and drug susceptibility methods are not evaluated enough for their clinical utility in extra-pulmonary tuberculosis cases including TBM. Nucleic acid amplification tests (NAATs) promise a rapid, definitive diagnosis of TBM; however, the performance of first-generation NAATs is suboptimal and variable. None of in-house or commercial NAAT assays are endorsed by the World Health Organization (WHO). The Xpert MTB/RIF test, the only WHO-endorsed point-of-care NAAT-based assay, is useful in determining that a patient has TBM. It is not useful in determining that a patient does not have TBM. There is a need to look for more rapid, economical, specific and sensitive assay for laboratory confirmation of TBM.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ADA:
-
Adenosine deaminase activity
- AFB:
-
Acid-fast bacilli
- CNS:
-
Central nervous system
- CRI:
-
Colourimetric redox indicator
- CSF:
-
Cerebrospinal fluid
- DNA:
-
Deoxyribonucleic acid
- DST:
-
Drug susceptibility testing
- ELISA:
-
Enzyme-linked immunosorbent assay
- FRET:
-
Fluorescence resonance energy transfer
- HIV:
-
Human immunodeficiency virus
- IGRA:
-
Interferon gamma release assays
- kDA:
-
Kilodalton
- LED:
-
Fluorescent light-emitting diode
- LJ:
-
Lowenstein–Jensen
- LPA:
-
Line probe assay
- MDR:
-
Multidrug resistance
- MGIT:
-
Mycobacterium growth indicator tube
- MODS:
-
Microscopic observation drug susceptibility
- MTBC:
-
Mycobacterium tuberculosis complex
- NAATs:
-
Nucleic acid amplification tests
- NRA:
-
Nitrate reductase assay
- NTM:
-
Non-tuberculous mycobacteria
- PCR:
-
Polymerase chain reaction
- REMA:
-
Resazurin microtitre assay
- TB:
-
Tuberculosis
- TBM:
-
Tuberculous meningitis
- WHO:
-
World Health Organization
- XDR:
-
Extensively drug resistance
- ZN:
-
Ziehl–Neelsen
References
Hopewell PC (1994) Overview of clinical tuberculosis. In: Bloom BR (ed) Tuberculosis pathogenesis, protection, and control. ASM Press, Washington, DC, pp 25–46
Thwaites GE, Caws M, Chau TT, Dung NT, Campbell JI, Phu NH, Hien TT, White NJ, Farrar JJ (2004) Comparison of conventional bacteriology with nucleic acid amplification (amplified mycobacterium direct test) for diagnosis of tuberculous meningitis before and after inception of antituberculosis chemotherapy. J Clin Microbiol 42:996–1002
World Health Organization (2013) Global tuberculosis report 2013. WHO, Geneva
Thwaites G, Fisher M, Hemingway C, Scott G, Solomon T, Innes J (2009) British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect 59:167e87
van Well GT, Paes BF, Terwee CB, Springer P, Roord JJ, Donald PR, van Furth AM, Schoeman JF (2009) Twenty years of pediatric tuberculous meningitis: a retrospective cohort study in the western cape of South Africa. Pediatrics 123:e1–e8
Thwaites G (2013) Tuberculous meningitis. Medicine 41:683–685
Solari L, Soto A, Agapito JC, Acurio V, Vargas D, Battaglioli T, Accinelli RA, Gotuzzo E, Stuyft PV (2013) The validity of cerebrospinal fluid parameters for the diagnosis of tuberculous meningitis. Int J Infect Dis 17:e1111–e1115
Thwaites GE, Tran TH (2005) Tuberculous meningitis: many questions, too few answers. Lancet Neurol 4:160–170
Torok ME, Chau TT, Mai PP, Phong ND, Dung NT, Chuong LV, Lee SJ, Caws M, de Jong MD, Hien TT, Farrar JJ (2008) Clinical and microbiological features of HIV-associated tuberculous meningitis in Vietnamese adults. PLoS One 3:e1772
Starke JR (1999) Tuberculosis of the central nervous system in children. Semin Pediatr Neurol 6:318–331
Vibha D, Bhatia R, Prasad K, Srivastava MP, Tripathi M, Kumar G, Singh MB (2012) Validation of diagnostic algorithm to differentiate between tuberculous meningitis and acute bacterial meningitis. Clin Neurol Neurosurg 114:639–644
Stewart SM (1953) The bacteriological diagnosis of tuberculous meningitis. J Clin Pathol 6:241–242
Kennedy DH, Fallon RJ (1979) Tuberculous meningitis. JAMA 241:264–268
Feng GD, Shi M, Ma L, Chen P, Wang BJ, Zhang M, Chang XL, Su XC, Yang YN, Fan XH, Dai W, Liu TT, He Y, Bian T, Duan LX, Li JG, Hao XK, Liu JY, Xue X, Song YZ, Wu HQ, Niu GQ, Zhang L, Han CJ, Lin H, Lin ZH, Liu JJ, Jian Q, Zhang JS, Tian Y, Zhou BY, Wang J, Xue CH, Han XF, Wang JF, Wang SL, Thwaites GE, Zhao G (2014) Diagnostic accuracy of intracellular mycobacterium tuberculosis detection for tuberculous meningitis. Am J Respir Crit Care Med 189:475–481
World Health Organization (2011) Fluorescent light-emitting diode (LED) microscopy for diagnosis of tuberculosis: policy statement. World Health Organization, Geneva
Hosoglu S, Geyik MF, Balik I, Aygen B, Erol S, Aygencel TG, Mert A, Saltoglu N, Dokmetas I, Felek S, Sunbul M, Irmak H, Aydin K, Kokoglu OF, Ucmak H, Altindis M, Loeb M (2002) Predictors of outcome in patients with tuberculous meningitis. Int J Tuberc Lung Dis 6:64–70
Hooker JA, Muhindi DW, Amayo EO, Mc'ligeyo SO, Bhatt KM, Odhiambo JA (2003) Diagnostic utility of cerebrospinal fluid studies in patients with clinically suspected tuberculous meningitis. Int J Tuberc Lung Dis 7:787–796
Balaji V, Daley P, Anand AA, Sudarsanam T, Michael JS, Sahni RD, Chordia P, George IA, Thomas K, Ganesh A (2010) Risk factors for MDR and XDR-TB in a tertiary referral hospital in India. PLoS One 5:e9527
Raj A, Singh N, Gupta KB, Chaudhary D, Yadav A, Chaudhary A, Agarwal K, Varma-Basil M, Prasad R, Khuller GK, Mehta PK (2016) Comparative evaluation of several gene targets for designing a multiplex-PCR for an early diagnosis of extrapulmonary tuberculosis. Yonsei Med J 57:88–96
Scarpellini P, Cinque SR, Delfanti F, Gianotti N, Terreni MR, Vago L, Lazzarin A (1995) Nested polymerase chain reaction for diagnosis and monitoring treatment response in AIDS patients with tuberculous meningitis. AIDS 9:895–900
Mazurek GH, Reddy V, Murphy D, Ansari T (1996) Detection of Mycobacterium tuberculosis in cerebrospinal fluid following immunomagnetic enrichment. J Clin Microbiol 34:450–453
Shankar P, Manjunath N, Mohan KK, Prasad K, Behari M, Ahuja GK (1991) Rapid diagnosis of tuberculous meningitis by polymerase chain reaction. Lancet 337:5–7
Pai M, Flores LL, Pai N, Hubbard A, Riley LW, Colford JM (2003) Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis 3:633–643
Denkinger CM, Schumacher SG, Boehme CC, Dendukuri N, Pai M, Steingart KR (2014) Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. Eur Respir J 44:435–446
World Health Organization (2015) Implementing tuberculosis diagnostics: policy framework. WHO, Geneva
Thwaites G, Chau TT, Mai NT, Drobniewski F, McAdam K, Farrar J (2000) Tuberculous meningitis. J Neurol Neurosurg Psychiatry 68:289–299
Niemann S, Richter E, Rüsch-Gerdes S (2000) Differentiation among members of the Mycobacterium tuberculosis complex by molecular and biochemical features: evidence for two pyrazinamide-susceptible subtypes of M. bovis. J Clin Microbiol 38:152–157
Parsons LM, Brosch R, Cole ST, Somoskövi Á, Loder A, Bretzel G, Van Soolingen D, Hale YM, Salfinger M (2002) Rapid and simple approach for identification of Mycobacterium tuberculosis complex isolates by PCR-based genomic deletion analysis. J Clin Microbiol 40:2339–2345
World Health Organization (2007) Use of liquid TB culture and drug susceptibility testing (DST) in low and medium income settings. WHO, Geneva
Baumann MH, Nolan R, Petrini M, Lee YG, Light RW, Schneider E (2007) Pleural tuberculosis in the United States: incidence and drug resistance. Chest 131:1125–1132
Robert J, Trystram D, Truffot-Pernot C, Jarlier V (2003) Multidrug-resistant tuberculosis: eight years of surveillance in France. Eur Resp J 22:833–837
Lai C-C, Liu W-L, Tan C-K, Huang Y-C, Chung K-P, Lee M-R, Hsueh P-R (2011) Differences in drug resistance profiles of Mycobacterium tuberculosis isolates causing pulmonary and extrapulmonary tuberculosis in a medical centre in Taiwan, 2000–2010. Int J Antimicrob Agents 38:125–129
Singh PK, Jain A (2015) Epidemiological perspective of drug resistant extrapulmonary tuberculosis. World J Clin Infect Dis 5:77–85
Jain A, Dixit P, Jaiswal I, Garg RK, Kumar R (2012) Drug resistance in mycobacterial isolates from meningitis cases. Pediatr Infect Dis J 31:13–17
World Health Organization (2013) Policy update: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children. WHO, Geneva
World Health Organization (2011) Noncommercial culture and drug-susceptibility testing methods for screening patients at risk for multidrug-resistant tuberculosis: policy statement. WHO, Geneva
Shikama M, Ferro e Silva R, Villela G, Sato D, Martins M, Giampaglia C, da Silva R, Ferro e Silva P, da Silva Telles M, Martin A (2009) Multicentre study of nitrate reductase assay for rapid detection of rifampicin-resistant M. tuberculosis. Int J Tuberc Lung Dis 13:377–380
Angeby KK, Klintz L, Hoffner SE (2002) Rapid and inexpensive drug susceptibility testing of Mycobacterium tuberculosis with a nitrate reductase assay. J Clin Microbiol 40:553–555
Moore DA, Evans CA, Gilman RH, Caviedes L, Coronel J, Vivar A, Sanchez E, Piñedo Y, Saravia JC, Salazar C (2006) Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 355:1539–1550
Palomino JC, Martin A, Camacho M, Guerra H, Swings J, Portaels F (2002) Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 1:2720–2720
Dixit P, Singh U, Sharma P, Jain A (2012) Evaluation of nitrate reduction assay, resazurin microtiter assay and microscopic observation drug susceptibility assay for first line antitubercular drug susceptibility testing of clinical isolates of M. tuberculosis. J Microbiol Methods 88:122–126
Neelakantan S, Jain A, Singh P, Prakash S, Dixit P, Kalyan R, Garg RK, Kumar R, Singh M (2014) Performance of newer and conventional diagnostic methods in detection of drug sensitive and resistant tuberculous meningitis. Asian Pac J Trop Dis 30:S648–S652
Nguyen QN, Dang MH, Do AT, Caws M, Torok E, Campbell J, Tran HC, Nguyen VC, Nguyen TC, Farrar J (2008) Routine diagnosis of Tuberculous Meningitis with MODS assay. Int J Infect Dis 31:e319–e320
Arias M, Mello FC, Pavón A, Marsico AG, Alvarado-Gálvez C, Rosales S, Pessôa CLC, Pérez M, Andrade MK, Kritski AL (2007) Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis. Clin Infect Dis 44:674–780
Montoro E, Lemus D, Echemendia M, Martin A, Portaels F, Palomino JC (2005) Comparative evaluation of the nitrate reduction assay, the MTT test, and the resazurin microtitre assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis. J Antimicrob Chemother 55:500–505
Martin A, Panaiotov S, Portaels F, Hoffner S, Palomino JC, Angeby K (2014) The nitrate reductase assay for the rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother 1:56–64
Nguyen LN, Kox LF, Pham LD, Kuijper S, Kolk AH (1996) The potential contribution of the polymerase chain reaction to the diagnosis of tuberculous meningitis. Arch Neurol 53:771–776
Caws M, Wilson SM, Clough C, Drobniewski F (2000) Role of IS6110 targeted PCR, biochemical, clinical and immunological criteria for diagnosis of tuberculous meningitis. J Clin Microbiol 38:3150–3155
Makeshkumar V, Madhavan R, Narayanan S (2014) Polymerase chain reaction targeting insertion sequence for the diagnosis of extrapulmonary tuberculosis. Indian J Med Res 139:161–166
Narayanan S, Parandaman V, Narayanan PR, Venkatesan P, Girish C, Mahadevan S, Rajajee S (2001) Evaluation of PCR using TRC4 and IS6110 primers in detection of tuberculous meningitis. J Clin Microbiol 39:2006–2008
Mehta PK, Raj A, Singh N, Khuller GK (2012) Diagnosis of extrapulmonary tuberculosis by PCR. FEMS Immunol Med Microbiol 66:20–36
Haldar S, Bose M, Chakrabarti P, Daginawala HF, Harinath BC, Kashyap RS, Kulkarni S, Majumdar A, Prasad HK, Rodrigues C, Srivastava R, Taori GM, Verma-Basil M, Tyagi JS (2011) Improved laboratory diagnosis of tuberculosis – the Indian experience. Tuberculosis 91:414–426
Sharma K, Sinha SK, Sharma A, Nada R, Prasad KK, Goyal K, Rana SS, Bhasin DK, Sharma M (2013) Multiplex PCR for rapid diagnosis of gastrointestinal tuberculosis. J Global Infect Dis 5:49–53
Sharma K, Gupta N, Sharma A, Singh G, Gupta PK, Rajwanshi A, Varma SC, Sharma M (2013) Multiplex polymerase chain reaction using insertion sequence 6110 (IS6110) and Mycobacterial protein fraction from BCG of Rm 0.64 in electrophoresis target genes for diagnosis of tuberculous lymphadenitis. Indian J Med Microbiol 31:24–28
Kashyap RS, Shekhawat SD, Nayak AR, Purohit HJ, Taori GM, Daginawala HF (2013) Diagnosis of tuberculosis infection based on synthetic peptides from Mycobacterium tuberculosis antigen 85 complex. Clin Neurol Neurosurg 115:678–683
Lang AM, Feris-Iglesias J, Pena C, Sanchez JF, Stockman L, Rys P, Roberts GD, Henry NK, Persing DH, Cockerill FR (1998) Clinical evaluation of Gen-Probe amplified direct test for the detection of Mycobacterium tuberculosis complex organisms in cerebrospinal fluid. J Clin Microbiol 36:2191–2194
Cloud JL, Shutt C, Aldous W, Woods G (2004) Evaluation of a modified Gen-Probe amplified direct test for detection of Mycobacterium tuberculosis complex organisms in cerebrospinal fluid. J Clin Microbiol 42:5341–5344
Bonington A, Strang JI, Klapper PE, Hood SV, Rubombora W, Penny M, Willers R, Wilkins EG (1998) Use of Roche AMPLICOR Mycobacterium tuberculosis PCR in early diagnosis of tuberculous meningitis. J Clin Microbiol 36:1251–1254
Bayram A, Celiksoz C, Karsligil T, Balci I (2006) Automatized PCR evaluation of Mycobacterium tuberculosis complex in respiratory and non-respiratory specimens. FEMS Immunol Med Microbiol 46:48–52
Solomons RS, van Elsland SL, Visser DH, Hoek KG, Marais BJ, Schoeman JF, van Furth AM (2014) Commercial nucleic acid amplification tests in tuberculous meningitis – a meta-analysis. Diagn Microbiol Infect Dis 78:398–403
Takahashi T, Nakayama T (2006) Novel technique of quantitative nested real-time PCR assay for Mycobacterium tuberculosis DNA. J Clin Microbiol 44:1029–1039
Takahashi T, Tamura M, Asami Y, Kitamura E, Saito K, Suzuki T, Takahashi SN, Matsumoto K, Sawada S, Yokoyama E, Takasu T (2008) Novel “wide range” quantitative nested real-time PCR assay for Mycobacterium tuberculosis DNA-development and methodology. J Clin Microbiol 46:1708–1715
Haldar S, Sharma N, Gupta VK, Tyagi JS (2009) Efficient diagnosis of tuberculous meningitis by detection of Mycobacterium tuberculosis DNA in cerebrospinal fluid filtrates using PCR. J Med Microbiol 58:616–624
Chaidir L, Ganiem AR, Vander Zanden A, Muhsinin S, Kusumaningrum T, Kusumadewi I, van der Ven A, Alisjahbana B, Parwati I, van Crevel R (2012) Comparison of real time IS6110-PCR, microscopy, and culture for diagnosis of tuberculous meningitis in a cohort of adult patients in Indonesia. PLoS One 7:e52001
Bhigjee AI, Padayachee R, Paruk H, Hallwirth-Pillay KD, Marais S, Connoly C (2007) Diagnosis of tuberculous meningitis: clinical and laboratory parameters. Int J Infect Dis 11:348–354
Lachnik J, Ackermann B, Bohrssen A, Maass S, Diephaus C, Puncken A, Stermann M, Bange FC (2002) Rapid cycle PCR and fluorimetry for detection of mycobacteria. J Clin Microbiol 40:3364–3373
Heginbothom ML, Magee JT, Flanagan PG (2003) Evaluation of the Idaho Technology Light Cycler PCR for the direct detection of Mycobacterium tuberculosis in respiratory specimens. Int J Tuberc Lung Dis 7:78–83
Lawn SD, Nicol MP (2011) XpertH MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol 6:1067–1082
Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, Milovic A (2010) Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 363:1005–1015
Bowles EC, Freyee B, van Ingen J, Mulder B, Boeree MJ, van Soolingen D (2011) Xpert MTB/RIF®, a novel automated polymerase chain reaction–based tool for the diagnosis of tuberculosis. Int J Tuberc Lung Dis 15:988–989
Nhu NT, Heemskerk D, Chau TT, Mai NT, Nghia HD, Loc PP, Ha DT, Merson L, Van Thinh TT, Day J, van Vinh CN (2014) Evaluation of GeneXpert MTB/RIF for diagnosis of tuberculous meningitis. J Clin Microbiol 52:226–233
Theron G, Peter J, van Zyl-Smit R, Mishra H, Streicher E, Murray S, Dawson R, Whitelaw A, Hoelscher M, Sharma S, Pai M (2011) Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med 184:132–140
Alvarez-Uria G, Azcona JM, Midde M, Naik PK, Reddy S, Reddy R (2012) Rapid diagnosis of pulmonary and extrapulmonary tuberculosis in HIV-infected patients. Comparison of LED fluorescent microscopy and the GeneXpert MTB/RIF assay in a district hospital in India. Tuberc Res Treat 2012:932862
Chang K, Lu W, Wang J, Zhang K, Jia S, Li F, Deng S, Chen M (2012) Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis. J Infect 64:580–588
Patel VB, Theron G, Lenders L, Matinyena B, Connolly C, Singh R, Coovadia Y, Ndung'u T, Dheda K (2013) Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous, meningitis in a high burden setting: a prospective study. PLoS Med 10:e1001536
Pettersson T, Klockars M, Weber TH, Somer H (1991) Diagnostic value of cerebrospinal fluid adenosine deaminase determination. Scand J Infect Dis 23:97–100
Ocana I, Martinez-Vazquez JM, Segura RM, Fernandez-De-Sevilla T, Capdevila JA (1983) Adenosine deaminase in pleural fluids. Test for diagnosis of tuberculous pleural effusion. Chest 84:51–53
Chen ML, Yu WC, Lam CW, Au KM, Kong FY, Chan AY (2004) Diagnostic value of pleural fluid adenosine deaminase activity in tuberculous pleurisy. Clin Chim Acta 341:101–107
Tuon FF, Litvoc MN, Lopes MI (2006) Adenosine deaminase and tuberculous pericarditis – a systematic review with meta-analysis. Acta Trop 99:67–74
Voigt MD, Kalvaria I, Trey C, Berman P, Lombard C, Kirsch RE (1989) Diagnostic value of ascites adenosine deaminase in tuberculous peritonitis. Lancet 1:751–754
Piras MA, Gakis C (1973) Cerebrospinal fluid adenosine deaminase activity in tuberculous meningitis. Enzyme 14:311–317
Chotmongkol V, Teerajetgul Y, Yodwut C (2006) Cerebrospinal fluid adenosine deaminase activity for the diagnosis of tuberculous meningitis in adults. Southeast Asian J Trop Med Public Health 37:948–952
Choi SH, Kim YS, Bae IG, Chung JW, Lee MS, Kang JM, Ryu J, Woo JH (2002) The possible role of cerebrospinal fluid adenosine deaminase activity in the diagnosis of tuberculous meningitis in adults. Clin Neurol Neurosurg 31:10–15
Moghtaderi A, Niazi A, Alavi-Naini R, Yaghoobi S, Narouie B (2010) Comparative analysis of cerebrospinal fluid adenosine deaminase in tuberculous and non-tuberculous meningitis. Clin Neurol Neurosurg 112:459–462
Choa B-H, Kima BC, Yoona G-J, Choia S-M, Changa J, Leea S-H, Parka M-S, Shinb JH, Kima M-K, Choa K-H (2013) Adenosine deaminase activity in cerebrospinal fluid and serum for the diagnosis of tuberculous meningitis. Clin Neurol Neurosurg 115:1831–1836
Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K (2010) Updated guidelines for using interferon gamma release assays to Detect Mycobacterium tuberculosis Infection d United States, 2010. MMWR Recomm Rep 59:1–25
Vidhate MR, Singh MK, Garg RK, Verma R, Shukla R, Goel MM, Makker A, Jain A (2011) Diagnostic and prognostic value of Mycobacterium tuberculosis complex specific interferon gamma release assay in patients with tuberculous meningitis. J Infect 62:400–403
Simmons CP, Thwaites GE, Quyen NT, Chau TT, Mai PP, Dung NT, Stepniewska K, White NJ, Hien TT, Farrar J (2005) The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses. J Immunol 175:579–590
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Jain, A. (2017). Methods of Microbiological Confirmation in Tuberculous Meningitis. In: Turgut, M., Akhaddar, A., Turgut, A., Garg, R. (eds) Tuberculosis of the Central Nervous System. Springer, Cham. https://doi.org/10.1007/978-3-319-50712-5_26
Download citation
DOI: https://doi.org/10.1007/978-3-319-50712-5_26
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-50711-8
Online ISBN: 978-3-319-50712-5
eBook Packages: MedicineMedicine (R0)